[go: up one dir, main page]

AR009398A1 - Utilizacion de inhibidores de la actividad del acido retinoico para el tratamiento de pieles sensibles y/o los danos agudos inducidos por los rayos u.v. - Google Patents

Utilizacion de inhibidores de la actividad del acido retinoico para el tratamiento de pieles sensibles y/o los danos agudos inducidos por los rayos u.v.

Info

Publication number
AR009398A1
AR009398A1 ARP970105043A ARP970105043A AR009398A1 AR 009398 A1 AR009398 A1 AR 009398A1 AR P970105043 A ARP970105043 A AR P970105043A AR P970105043 A ARP970105043 A AR P970105043A AR 009398 A1 AR009398 A1 AR 009398A1
Authority
AR
Argentina
Prior art keywords
acid
benzoic
benzoic acid
dimethyl
adamantyl
Prior art date
Application number
ARP970105043A
Other languages
English (en)
Original Assignee
Galderma Ct Internat De Rech S Dermatologiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Ct Internat De Rech S Dermatologiques filed Critical Galderma Ct Internat De Rech S Dermatologiques
Publication of AR009398A1 publication Critical patent/AR009398A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/445—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Utilizacion de al menos un inhibidor de la actividad del ácido en una composicion cosmética o para la fabricacion de una composicion farmacéutica,estando destinados el inhibidor de la actividad del ácido retinoico o la composicion farmacéutica, al tratamiento de pieles sensibles y/o los danoscutáneos agudos inducidos por los rayos U.V. El inhibidor de la actividad del ácido retinoico se elige especialmente entre los siguientes compuestos: ácido4-[7-(1-adamantil)-6-metoxietoximetoxi-2-naftil]benzoico, ácido 4-[7-(1- adamantil)-6-metoxietoximetoxi-2-naftil]salicílico, ácido 4-{[5,6-dihidro-5,5-dimetil-8-(4-metilfenil)-2-naftalenil]etinil}benzoico, ácido (E)-4-[2-(4,4- dimetil-7-heptiloxi-1,1-dioxo-3,4-dihidro-2H-1-benzotiopiran-6-il)propenil]benzoico, ácido 4-[4,5,7,8,9,10-hexahidro-7,7,10,10-tetrametil-1-(3- piridilmetil)antra[1,2-b]pirrol-3-il]benzoico, ácido 4-[4,5,7,8,9,10-hexahidro-7,7,10,10-tetrametil-1-(3-piridilmetil)tioantra[1,2-b]pirrol-3-il]benzoico, ácido 4-[4,5,7,8,9,10-hexahidro-7,7,10,10-tetrametil-1-(3-piridilmetil)antra[1,2-d]pirazol-3-il]benzoico, ácido 4-[3-(diamantil)-4-metoxibenzamido]benzoico ácido 4-[3-(diamantil)-4-metoxibenzoiloxi]benzoico, ácido 4-(N-fenil-5,6,7,8-tetrahidro-5,5,8,8,-tetrametilnafto[2,3-d]imidazol-2-il)benzoico, ácido 4-(N- bencil-5,6,7,8-tetrahidro-5,5,8,8-tetrametilnafto[2,3-d]imidazol-2-il)benzoico,ácido 4-(5H-7,8,9,10-tetrahidro-5,7,7,10,10-pentametilbenzo[c]-nafto[2,3-b] (1,4]diazepin-3-il)benzoico, ácido 4-[1-(1-metoxi-2,2,2-trifluoroetil)-5,6,7,8-tetrahidro-5,5,8,8-tetrametil-3-antracenil]benzoico, ácido 7-[3-(1-adamantil) -4-metoxifenil]-3,7-dimetil-2,4,6-heptatrienoico, ácido 6-[7-(1-adamantil)-6-metoxietoximetoxi-2-naftil]nicotínico, ácido 4-(5,5-dimetil-8-fenil-5,6-dihidro -naftalen-2-iletinil)benzoico, ácido 4-(5,5-dimetil-8-p-tolil-5,6-dihidro
ARP970105043A 1996-10-31 1997-10-30 Utilizacion de inhibidores de la actividad del acido retinoico para el tratamiento de pieles sensibles y/o los danos agudos inducidos por los rayos u.v. AR009398A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9613362A FR2755011B1 (fr) 1996-10-31 1996-10-31 Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v.

Publications (1)

Publication Number Publication Date
AR009398A1 true AR009398A1 (es) 2000-04-12

Family

ID=9497258

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105043A AR009398A1 (es) 1996-10-31 1997-10-30 Utilizacion de inhibidores de la actividad del acido retinoico para el tratamiento de pieles sensibles y/o los danos agudos inducidos por los rayos u.v.

Country Status (17)

Country Link
US (1) US6248749B1 (es)
EP (1) EP0892633B1 (es)
JP (1) JPH11503471A (es)
AR (1) AR009398A1 (es)
AT (1) ATE233542T1 (es)
AU (1) AU713943B2 (es)
BR (1) BR9706902A (es)
CA (1) CA2241244C (es)
DE (1) DE69719495T2 (es)
DK (1) DK0892633T3 (es)
ES (1) ES2196313T3 (es)
FR (1) FR2755011B1 (es)
MX (1) MX9805290A (es)
NZ (1) NZ330746A (es)
PT (1) PT892633E (es)
WO (1) WO1998018440A2 (es)
ZA (1) ZA979753B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733684B1 (fr) 1995-05-03 1997-05-30 Cird Galderma Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique
AU728122B2 (en) * 1997-08-18 2001-01-04 Netpro Pty Limited Improvements in roof structures
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
FR2783423B1 (fr) * 1998-09-23 2002-06-14 Oreal Systeme de delivrance d'actif comprenant, sur une structure en film, une composition a base d'un derive d'acide salicylique, et ses utilisations
FR2804323B1 (fr) * 2000-01-31 2006-07-07 Galderma Res & Dev Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
JP2001233764A (ja) * 2000-02-22 2001-08-28 Hisamitsu Pharmaceut Co Inc Ｎ−置換−ｏ−トルイジン誘導体からなる鎮痒剤
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
FR2847167A1 (fr) * 2002-11-15 2004-05-21 Galderma Res & Dev UTILISATION D'UN ANTAGONISTE DES RECEPTEURS RARs POUR POTENTIALISER L'ACTION DU TGFb
AU2003302070A1 (en) * 2002-11-15 2004-06-15 Galderma Research And Development, S.N.C. USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta
GB2503623B (en) * 2011-03-21 2015-10-14 Coloright Ltd A method for predicting a result of a treatment of keratinous fibers
US9316580B2 (en) 2011-03-21 2016-04-19 Coloright Ltd. Systems for custom coloration
EP3508254A1 (en) 2013-09-26 2019-07-10 Coloright Ltd. System for preparing a hair coloring composition
CN106572736B (zh) 2014-04-27 2020-01-31 卡拉莱特有限公司 用于定制毛发染色的方法与装置
MX367969B (es) 2014-04-27 2019-09-11 Coloright Ltd Aparato y metodo para analizar pelo y/o predecir un resultado de un tratamiento de coloracion del pelo.
US10292482B2 (en) 2017-01-06 2019-05-21 Coloright Ltd. Hair-holder, hair-reader comprising the same, and methods for optically acquiring data from hair

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5428052A (en) * 1984-09-19 1995-06-27 Centre Internationale De Recherches Dermatologiques (C.I.R.D.) Aromatic heterocyclic derivatives and their therapeutic and cosmetic use
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
LU86022A1 (fr) * 1985-07-25 1987-02-04 Cird Derives aromatiques polycyliques,leur procede de preparation et leur application dans les domaines pharmaceutique et cosmetique
EP0611301B1 (en) * 1990-04-26 2003-06-11 The Procter & Gamble Company Chelator compositions comprising oxime compounds
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
CA2093577C (en) * 1992-05-07 2006-01-03 Michael Klaus Alkyl or alkoxy substituted s-heterocyclic retinoids
US5516793A (en) * 1993-04-26 1996-05-14 Avon Products, Inc. Use of ascorbic acid to reduce irritation of topically applied active ingredients
FR2719044B1 (fr) * 1994-04-26 1996-05-31 Cird Galderma Nouveaux composés bi-aromatiques acétylénés à groupement adamantyle, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2719041B1 (fr) * 1994-04-26 1996-05-31 Cird Galderma Nouveaux composés polyéniques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
US5804203A (en) * 1994-12-21 1998-09-08 Cosmederm Technologies Topical product formulations containing strontium for reducing skin irritation
US5770383A (en) * 1994-12-30 1998-06-23 Ligand Pharmaceuticals, Inc. Tricyclic retinoids, methods for their production and use
US5807900A (en) * 1995-03-31 1998-09-15 Hoffmann-La Roche, Inc. Method for identifying compounds having increased activity for the repair of skin photodamage
FR2733684B1 (fr) * 1995-05-03 1997-05-30 Cird Galderma Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique
FR2735371B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Procede pour identifier des composes antagonistes des recepteurs rars
FR2741878B1 (fr) * 1995-12-01 1998-01-09 Cird Galderma Composes biaromatiques portant un groupement adamantyl en ortho, compositions pharmaceutiques et cosmetiques les contenant et utilisations
US5728846A (en) * 1996-12-12 1998-03-17 Allergan Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives

Also Published As

Publication number Publication date
AU713943B2 (en) 1999-12-16
PT892633E (pt) 2003-07-31
AU4872897A (en) 1998-05-22
FR2755011B1 (fr) 1998-11-20
ATE233542T1 (de) 2003-03-15
NZ330746A (en) 2000-06-23
BR9706902A (pt) 1999-07-20
EP0892633B1 (fr) 2003-03-05
FR2755011A1 (fr) 1998-04-30
DE69719495D1 (de) 2003-04-10
US6248749B1 (en) 2001-06-19
MX9805290A (es) 1998-10-31
DK0892633T3 (da) 2003-06-30
WO1998018440A2 (fr) 1998-05-07
EP0892633A2 (fr) 1999-01-27
ES2196313T3 (es) 2003-12-16
CA2241244A1 (fr) 1998-05-07
DE69719495T2 (de) 2003-10-30
JPH11503471A (ja) 1999-03-26
ZA979753B (en) 1998-05-22
CA2241244C (fr) 2005-01-11
WO1998018440A3 (fr) 1998-08-06

Similar Documents

Publication Publication Date Title
AR009398A1 (es) Utilizacion de inhibidores de la actividad del acido retinoico para el tratamiento de pieles sensibles y/o los danos agudos inducidos por los rayos u.v.
AR008638A1 (es) Utilizacion de un inhibidor de la actividad del acido retinoico en una composicion cosmetica o para la preparacion de una composicion farmaceutica
UY24816A1 (es) Sulfonamidas agonistas de prostaglandinas para la prevención y restauración de la masa ósea
AR008386A1 (es) DERIVADOS DE BENZIMIDAZOL CON ACTIVIDAD ANTIHISTAMINICA Y COMPOSICIoN FARMACÉUTICA ANTIHISTAMINICA QUE LOS CONTIENE.
UY26186A1 (es) Inhibidores de metaloproteasas
IT1286067B1 (it) Esteri di acidi ossimsolfonici e loro impiego come acidi solfonici latenti
AR003116A1 (es) Compuestos triciclicos utiles para inhibir la funcion de la proteina g y para el tratamiento de enfermedades proliferativas, composicion farmaceutica que los comprende y el uso de dichos compuestos para la manufactura de medicamentos
ES2152485T3 (es) Procedimiento para preparar comprimidos que contienen amoxicilina y clavulanato recubiertos de una pelicula polimerica acuosa.
ES2084639T3 (es) Derivados de acido n-(pirrolo(2,3-d)pirimidin-3-ilacetil)-glutamico.
SV2002000197A (es) Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas ref. pc10602/20073/bb
DK389480A (da) Derivater af 6beta-hydroxyalkyl-penicillansyrer til anvendelse som beta-lactamse-inhibitorer
ES2126684T3 (es) Utilizacion de derivados de acidos carboxilicos aromaticos para la preparacion de medicamentos.
IT1231760B (it) Derivati di acido piridoncarbossilico e loro sali, procedimento per produrre gli stessi e agenti antibatterici che li contengono
ITFI930030A1 (it) Composti pirrol-amidinici, e loro sali farmaceuticamente accettabili processi di preparazione e composizioni farmaceutiche che li contengono
ES2070100T3 (es) Material de registro termosensible utilizando derivados de acido ftalico.
ES8700670A1 (es) Derivados de cefalosporina
NO991994D0 (no) Substituerte 4-bifenyl-4-hydroksysm°rsyrederivater som matriks-metalloproteaseinhibitorer
FI950842L (fi) Enkefalinaasin inhibiittoreina käyttökelpoisia uusia 2-substituoituja trisyklisiä indaani-2-merkaptoasetyyliamidijohdannaisia
DE69619259D1 (de) Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase
DK0559752T3 (da) Optiske isomerer af 7-[3-1-(dialkylmethyl-1-amino)-1-pyrrolidinyl]-quinoloner og -naphthyridoner som antibakterielle stoffe
DE60012287D1 (de) 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphto[2,3-d][1,3]dioxol-6(5aH)-on - Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
TR199902720T2 (xx) Nitrik oksit sentaz�n�n inhibit�rleri olarak amidin t�revleri.
ES2162063T3 (es) Derivados de estirilbencimidazol como inhibidores de la proliferacion de las celulas de la musculatura lisa.
BRPI0013750B8 (pt) intermediários para a produção de derivados de ácido naftiridina-3-carboxílico
ES2110030T3 (es) Nuevos derivados de 17-hidroxiiminometil-5beta,14beta-androstano activos sobre el sistema cardiovascular, procesos para su preparacion y composiciones farmaceuticas que contienen los mismos.

Legal Events

Date Code Title Description
FB Suspension of granting procedure